Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.
暂无分享,去创建一个
Alan A. Wilson | S. Houle | N. Ginovart | A. Wilson | J. Meyer | D. Hussey | S Houle | J H Meyer | A A Wilson | N Ginovart | V Goulding | D Hussey | K Hood | Verdell S. Goulding | J. Meyer | K. Hood | V. Goulding | Karen Hood | J. Meyer
[1] Alan A. Wilson,et al. Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. , 2000, Nuclear medicine and biology.
[2] Marc Laruelle,et al. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites , 1988, Biological Psychiatry.
[3] M Slifstein,et al. In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] D. Murphy,et al. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. , 1993, Brain research. Molecular brain research.
[5] S. Houle,et al. Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of (11)C-Labeled 2-(Phenylthio)araalkylamines. , 2000, Journal of medicinal chemistry.
[6] H. Kung,et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] M. Briley,et al. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. , 1996, European journal of pharmacology.
[8] J. Marcusson,et al. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue , 1989, Brain Research.
[9] S. Haber,et al. Immunocytochemical localization of the dopamine transporter in human brain , 1999, The Journal of comparative neurology.
[10] C. Montigny,et al. Desensitization of the neuronal 5-HT carrier following its long-term blockade , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[11] C. Halldin,et al. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. , 1999, The American journal of psychiatry.
[12] Marc Laruelle,et al. Methyl 3β‐(4‐[125I]Iodophenyl)Tropane‐2β‐Carboxylate In Vitro Binding to Dopamine and Serotonin Transporters Under “Physiological” Conditions , 1994 .
[13] Colin Studholme,et al. An overlap invariant entropy measure of 3D medical image alignment , 1999, Pattern Recognit..
[14] Alan A. Wilson,et al. The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. , 2001, The American journal of psychiatry.
[15] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[16] A Frazer,et al. Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level , 1999, The Journal of Neuroscience.
[17] F. Artigas,et al. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. , 1992, European journal of pharmacology.
[18] Linda Carpenter,et al. Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography , 1998, Biological Psychiatry.
[19] J. Palacios,et al. Autoradiography of antidepressant binding sites in the human brain: localization using [3h]imipramine and [3h]paroxetine , 1988, Neuroscience.
[20] Alexander Neumeister,et al. [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder , 2000, Biological Psychiatry.
[21] T. Reader,et al. [3H]Paroxetine Binding and Serotonin Content of Rat Cortical Areas, Hippocampus, Neostriatum, Ventral Mesencephalic Tegmentum, and Midbrain Raphe Nuclei Region Following p‐Chlorophenylalanine and p‐Chloroamphetamine Treatment , 1992, Journal of neurochemistry.
[22] J. Seibyl,et al. Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT , 2000, Neurobiology of Aging.
[23] M. Fava,et al. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder. , 2000, The Journal of clinical psychiatry.
[24] Alan A. Wilson,et al. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. , 1998, The American journal of psychiatry.
[25] S. Kapur,et al. Is amoxapine an atypical antipsychotic? positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy , 1999, Biological Psychiatry.
[26] Zsolt Szabo,et al. Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652 , 1995, Synapse.
[27] R. Blakely,et al. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.
[28] J. Feighner,et al. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. , 1999, The Journal of clinical psychiatry.
[29] Alan A. Wilson,et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.
[30] H. Kung,et al. Simplified quantification and reproducibility studies of dopamine D2-receptor binding with iodine-123-IBF SPECT in healthy subjects. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[32] J. Wernicke,et al. Low-dose fluoxetine therapy for depression. , 1988, Psychopharmacology bulletin.
[33] Masanori Ichise,et al. Modeling of Receptor Ligand Data in PET and SPECT Imaging: A Review of Major Approaches , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[34] R. Mowbray. The Hamilton Rating Scale for depression: a factor analysis , 1972, Psychological Medicine.
[35] M. Gobbi,et al. p‐Chlorophenylalanine Changes Serotonin Transporter mRNA Levels and Expression of the Gene Product , 1996, Journal of neurochemistry.